{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Abnormal accumulation of a-synuclein in Lewy bodies is a neuropathological hallmark of both sporadic and familial Parkinson's disease (PD). Although mutations in a-synuclein have been identified in autosomal dominant PD, the mechanism by which dopaminergic cell death occurs remains unknown.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as related to the abnormal accumulation of a-synuclein leading to dopaminergic cell death in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated transcriptional changes in neuroblastoma cell lines transfected with either normal or mutant (A30P or A53T) a-synuclein using microarrays, with confirmation of selected genes by quantitative RT-PCR. Gene products whose expression was found to be significantly altered included members of diverse functional groups such as stress response, transcription regulators, apoptosis-inducing molecules, transcription factors and membrane-bound proteins.",
          "judgment": "Yes",
          "reasoning": "The gene expression assay, particularly focusing on dopamine synthesis related genes, effectively models a part of the PD disease mechanism which relates to dopaminergic cell death. Although it is a broad assay type, the focus on dopamine synthesis genes makes it applicable.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Total RNA prepared from four cell lines (two each over-expressing wild-type and A53T a-synuclein), and one cell line containing pcDNA3 vector alone were hybridized to Affymetrix...Pairwise comparisons with the vector-only cell line were carried out...Total RNA was isolated from clonal cell lines using Trizol (Invitrogen), according to manufacturer's instructions...",
          "judgment": "Yes",
          "reasoning": "Wild-type and empty vector (mock) controls were used. The experiment was repeated as noted in the quote: Total RNA prepared from four cell lines (two each over-expressing wild-type and A53T a-synuclein), and one cell line containing pcDNA3 vector",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "We subsequently validated array results using quantitative real time RT-PCR, and expanded the analysis to include a second mutation (A30P: Table 3).",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (A53T) and A30P were used as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Using Onto-Express we found that the number of transcriptional activator genes that were differentially expressed in the a-synuclein cell lines was more than expected by chance alone. This suggests that a-synuclein has a distinct and specific effect on transcription.",
          "judgment": "No",
          "reasoning": "The paper did not include specific statistical analyses sufficient to calculate an OddsPath value. Instead, there were statistical analyses showing significance of the gene expression differences overall using Onto-Express.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "We subsequently validated array results using quantitative real time RT-PCR, and expanded the analysis to include a second mutation (A30P: Table 3).",
          "judgment": "Yes",
          "reasoning": "A53T and A30P were used and measured with appropriate controls.",
          "next_step_or_outcome": "Count the number of benign/pathogenic variants used"
        },
        {
          "step_name": "Count number of variants",
          "extracted_paper_info": "The paper uses wild-type/control vector and two mutant variants A30P and A53T.",
          "judgment": "N/A",
          "reasoning": "Two pathogenic variants were used. This is less than 11, so max evidence is supporting.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The transcriptional assay, combined with controls and replication, supports the pathogenicity of A30P. There were statistical analyses to show the gene expression changes are significant overall. However, since fewer than 11 variant controls were used, the strength of evidence is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Abnormal accumulation of a-synuclein in Lewy bodies is a neuropathological hallmark of both sporadic and familial Parkinson's disease (PD). Although mutations in a-synuclein have been identified in autosomal dominant PD, the mechanism by which dopaminergic cell death occurs remains unknown.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as related to the abnormal accumulation of a-synuclein leading to dopaminergic cell death in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated transcriptional changes in neuroblastoma cell lines transfected with either normal or mutant (A30P or A53T) a-synuclein using microarrays, with confirmation of selected genes by quantitative RT-PCR. Gene products whose expression was found to be significantly altered included members of diverse functional groups such as stress response, transcription regulators, apoptosis-inducing molecules, transcription factors and membrane-bound proteins.",
          "judgment": "Yes",
          "reasoning": "The gene expression assay, particularly focusing on dopamine synthesis related genes, effectively models a part of the PD disease mechanism which relates to dopaminergic cell death. Although it is a broad assay type, the focus on dopamine synthesis genes makes it applicable.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Total RNA prepared from four cell lines (two each over-expressing wild-type and A53T a-synuclein), and one cell line containing pcDNA3 vector alone were hybridized to Affymetrix...Pairwise comparisons with the vector-only cell line were carried out...Total RNA was isolated from clonal cell lines using Trizol (Invitrogen), according to manufacturer's instructions...",
          "judgment": "Yes",
          "reasoning": "Wild-type and empty vector (mock) controls were used. The experiment was repeated as noted in the quote: Total RNA prepared from four cell lines (two each over-expressing wild-type and A53T a-synuclein), and one cell line containing pcDNA3 vector",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "We subsequently validated array results using quantitative real time RT-PCR, and expanded the analysis to include a second mutation (A30P: Table 3).",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (A53T) and A30P were used as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Using Onto-Express we found that the number of transcriptional activator genes that were differentially expressed in the a-synuclein cell lines was more than expected by chance alone. This suggests that a-synuclein has a distinct and specific effect on transcription.",
          "judgment": "No",
          "reasoning": "The paper did not include specific statistical analyses sufficient to calculate an OddsPath value. Instead, there were statistical analyses showing significance of the gene expression differences overall using Onto-Express.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "We subsequently validated array results using quantitative real time RT-PCR, and expanded the analysis to include a second mutation (A30P: Table 3).",
          "judgment": "Yes",
          "reasoning": "A53T and A30P were used and measured with appropriate controls.",
          "next_step_or_outcome": "Count the number of benign/pathogenic variants used"
        },
        {
          "step_name": "Count number of variants",
          "extracted_paper_info": "The paper uses wild-type/control vector and two mutant variants A30P and A53T.",
          "judgment": "N/A",
          "reasoning": "Two pathogenic variants were used. This is less than 11, so max evidence is supporting.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The transcriptional assay, combined with controls and replication, supports the pathogenicity of A53T. There were statistical analyses to show the gene expression changes are significant overall. However, since fewer than 11 variant controls were used, the strength of evidence is PS3_supporting."
    }
  ]
}
